YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)

Parker Waichman Alonso LLP Headlines by Topic

Enbrel

FDA Releases More Humira, Enbrel, Remicade Info

Sep 1, 2009 | Parker Waichman Alonso LLP
Federal regulators have released  more information regarding cancers associated with drugs like Humira, Enbrel, and Remicade.  Last month,...

Group Calls For Study Of Arthritis Drugs

Jul 1, 2009 | Parker Waichman Alonso LLP
Arthritis and other autoimmune medications have made recent headlines over a variety of issues including links to serious opportunistic fungal...

Simponi Carries Risk of Possibly Fatal Fungal Infections

May 29, 2009 | Parker Waichman Alonso LLP
Simponi, a new rheumatoid arthritis drug, can cause severe and potentially fatal fungal infections, according to a new warning released yesterday by...

Humira, Cimzia, Enbrel and Remicade to Bear Stronger Infection Warnings

Sep 4, 2008 | Parker Waichman Alonso LLP
Federal regulators have ordered the makers of Humira, Cimzia, Enbrel, and Remicade to strengthen the existing warnings about opportunistic fungal...

Despite Enbrel Risks, FDA Panel Recommends it for Psoriasis in Children

Jun 19, 2008 | Parker Waichman Alonso LLP
A Food & Drug Administration (FDA) advisory panel has recommended that the agency approve Enbrel to treat moderate-to-severe psoriasis in...

Enbrel Infection Risk Cited

Jun 16, 2008 | Parker Waichman Alonso LLP
Enbrel has been linked to sometimes deadly infections when administered to children, casting doubts that the Food & Drug Administration (FDA)...

Humira, Enbrel, Remicade Being Investigated for Cancer Link

Jun 4, 2008 | Parker Waichman Alonso LLP
Humira and other drugs used to treat autoimmune disorders are being investigated by federal regulators amid concern that they might be linked to...

Enbrel Black Box Warns of Tuberculosis Risk

May 1, 2008 | Parker Waichman Alonso LLP
Enbrel, a drug used to treat psoriasis that has been associated with serious infections, including tuberculosis in some patients.  Enbrel's...

More Trouble for Amgen, as Enbrel Gets Stronger Infection Warnings

Mar 18, 2008 | Parker Waichman Alonso LLP
Enbrel, a popular treatment for rheumatoid arthritis and psoriasis, is getting stronger warnings about serious infections associated with its...

Enbrel Marketing Focus of New Jersey Amgen Probe

Jan 18, 2008 | Parker Waichman Alonso LLP
The marketing of Enbrel is the now the subject of an investigation by the New Jersey Attorney General’s Office.   The Enbrel probe...

Page 1/2 [first] [prev] 1 2 [next] [last]

Enbrel
* Denotes required field.

Title

* First Name

* Last Name

* Email Address

* Phone Number

Cell Phone Number

Office Phone Number

Street Address

Apartment/Suite

City

State

Zip Code

Please provide the best method and times to contact you:

Date of birth of person injured
(mm-dd-yyyy):

Date you started taking the drug (mm-yyyy):

Date you stopped taking the drug (mm-yyyy):

What condition was this medication prescribed to treat?

Medical problems since taking Enbrel:





Please further describe side effects:

Other Info:

No Yes, I agree to the Parker Waichman Alonso LLP disclaimers.Click here to review all.

Yes, I would like to receive the Parker Waichman Alonso LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Home | Defective Drugs | Medical Devices | Toxic Substances | Accidents | Product Liability | Malpractice | Diseases
Nursing Home Negligence | Food Poisoning | Other Topics | Social Security Disability | Contact
Statement of Clients' Rights | Site Map | Drug Injury Search | Vioxx | Mesothelioma | Permax | Dostinex | Composix Kugel Mesh X Large Patch
Ortho Evra | Fosamax | Personal Injury Lawyer | Fusarium Keratitis | Stevens Johnson Syndrome | Florida Personal Injury Law Firm

© 2002-2009 YourLawyer.com®. All Rights Reserved.

Please note that you are not considered a client until you have signed a retainer agreement and your case has been accepted by us.
Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Attorney Advertising

Parker Waichman Personal Injury News